Yassine Lalami

Outpatient Oral Antibiotics for Febrile Neutropenic Cancer Patients Using a Score Predictive for Complications

Jean Klášterský, Marianne Paesmans, Aspasia Georgala et al. · Journal of Clinical Oncology · 2006 · 189 citations

Can we predict the duration of chemotherapy-induced neutropenia in febrile neutropenic patients, focusing on regimen-specific risk factors? A retrospective analysis

Yassine Lalami, M. Paesmans, F. Muanza et al. · Annals of Oncology · 2005 · 50 citations · Full text

Disease Progression, Regimen-specific Risk Factors, Medicine +8

Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)

Jean-Pascal Machiels, Paolo Bossi, Jessica Menis et al. · Annals of Oncology · 2018 · 41 citations · Full text

A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck

J.-P. Machiels, Pol Specenier, Andreas Dietz et al. · Cancer Chemotherapy and Pharmacology · 2015 · 30 citations

Concept Trial, Squamous Cell Carcinoma, Medicine +7

Phase II trial evaluating the efficacy of sorafenib (BAY 43‐9006) and correlating early fluorodeoxyglucose positron emission tomography–CT response to outcome in patients with recurrent and/or metastatic head and neck cancer

Yassine Lalami, C. Garcia, Patrick Flamen et al. · Head & Neck · 2014 · 27 citations